These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24565443)
21. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer. Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224 [TBL] [Abstract][Full Text] [Related]
22. Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction. Gramling MW; Beaulieu LM; Church FC Exp Cell Res; 2010 Feb; 316(3):314-28. PubMed ID: 19891966 [TBL] [Abstract][Full Text] [Related]
23. HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells. Amornsupak K; Thongchot S; Thinyakul C; Box C; Hedayat S; Thuwajit P; Eccles SA; Thuwajit C BMC Cancer; 2022 May; 22(1):578. PubMed ID: 35610613 [TBL] [Abstract][Full Text] [Related]
24. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
25. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475 [TBL] [Abstract][Full Text] [Related]
26. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Jeong YJ; Choi Y; Shin JM; Cho HJ; Kang JH; Park KK; Choe JY; Bae YS; Han SM; Kim CH; Chang HW; Chang YC Food Chem Toxicol; 2014 Jun; 68():218-25. PubMed ID: 24675423 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells. Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031 [TBL] [Abstract][Full Text] [Related]
28. Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. Kim JS; Kang CG; Kim SH; Lee EO J Nat Prod; 2014 May; 77(5):1135-9. PubMed ID: 24828286 [TBL] [Abstract][Full Text] [Related]
29. Bisphenol A Induces Migration through a GPER-, FAK-, Src-, and ERK2-Dependent Pathway in MDA-MB-231 Breast Cancer Cells. Castillo Sanchez R; Gomez R; Perez Salazar E Chem Res Toxicol; 2016 Mar; 29(3):285-95. PubMed ID: 26914403 [TBL] [Abstract][Full Text] [Related]
30. Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways. Leung HW; Wang Z; Yue GG; Zhao SM; Lee JK; Fung KP; Leung PC; Lau CB; Tan NH Biochim Biophys Acta; 2015 Aug; 1853(8):1827-40. PubMed ID: 25953046 [TBL] [Abstract][Full Text] [Related]
31. A new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer. Yuan Q; Cai S; Zhang X; Liu Z; Li Z; Luo X; Xiong C; Wang J; Hu J; Ruan J Cancer Lett; 2012 Nov; 324(2):210-20. PubMed ID: 22652174 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997 [TBL] [Abstract][Full Text] [Related]
33. Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells. Castillo-Sanchez R; Villegas-Comonfort S; Galindo-Hernandez O; Gomez R; Salazar EP Cell Biol Toxicol; 2013 Aug; 29(4):303-19. PubMed ID: 23955088 [TBL] [Abstract][Full Text] [Related]
34. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway. Tsai PC; Hsieh CY; Chiu CC; Wang CK; Chang LS; Lin SR Toxicon; 2012 Oct; 60(5):734-43. PubMed ID: 22683533 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro. Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695 [TBL] [Abstract][Full Text] [Related]
36. Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2. Allison SE; Petrovic N; Mackenzie PI; Murray M Biochem Pharmacol; 2015 Aug; 96(4):306-14. PubMed ID: 26067757 [TBL] [Abstract][Full Text] [Related]
37. Oleic acid induces migration through a FFAR1/4, EGFR and AKT-dependent pathway in breast cancer cells. Marcial-Medina C; Ordoñez-Moreno A; Gonzalez-Reyes C; Cortes-Reynosa P; Perez Salazar E Endocr Connect; 2019 Mar; 8(3):252-265. PubMed ID: 30721135 [TBL] [Abstract][Full Text] [Related]
38. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687 [TBL] [Abstract][Full Text] [Related]
39. PKB/Akt-dependent regulation of cell motility. Xue G; Hemmings BA J Natl Cancer Inst; 2013 Mar; 105(6):393-404. PubMed ID: 23355761 [TBL] [Abstract][Full Text] [Related]
40. Ceramide Kinase Is Upregulated in Metastatic Breast Cancer Cells and Contributes to Migration and Invasion by Activation of PI 3-Kinase and Akt. Schwalm S; Erhardt M; Römer I; Pfeilschifter J; Zangemeister-Wittke U; Huwiler A Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]